Phreesia (PHR)
(Delayed Data from NYSE)
$21.03 USD
+0.04 (0.19%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $21.03 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Income Statements
Fiscal Year end for Phreesia, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 356 | 281 | 213 | 149 | 125 |
Cost Of Goods | 124 | 109 | 81 | 52 | 45 |
Gross Profit | 232 | 172 | 132 | 96 | 80 |
Selling & Adminstrative & Depr. & Amort Expenses | 369 | 348 | 249 | 122 | 95 |
Income After Depreciation & Amortization | -136 | -177 | -117 | -26 | -15 |
Non-Operating Income | 1 | 1 | -1 | -2 | -7 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -135 | -176 | -118 | -27 | -22 |
Income Taxes | 2 | 0 | 0 | 0 | -2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -137 | -176 | -118 | -27 | -20 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -137 | -176 | -118 | -27 | -20 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -106 | -149 | -93 | -7 | 1 |
Depreciation & Amortization (Cash Flow) | 31 | 27 | 24 | 18 | 16 |
Income After Depreciation & Amortization | -136 | -177 | -117 | -26 | -15 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 54.56 | 52.44 | 49.89 | 39.52 | 20.30 |
Diluted EPS Before Non-Recurring Items | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 |
Diluted Net EPS (GAAP) | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 |
Fiscal Year end for Phreesia, Inc falls in the month of January .
All items in Millions except EPS data.
7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 | |
---|---|---|---|---|---|
Sales | 102.12 | 101.22 | 95.00 | 91.62 | 85.83 |
Cost Of Goods | 32.81 | 34.02 | 31.77 | 30.94 | 30.30 |
Gross Profit | 69.30 | 67.20 | 63.23 | 60.68 | 55.53 |
SG&A, R&D, and Dept/Amort Expenses | 86.52 | 86.61 | 92.80 | 92.72 | 92.48 |
Income After SG&A, R&D, and Dept/Amort Expenses | -17.22 | -19.41 | -29.57 | -32.04 | -36.95 |
Non-Operating Income | -0.04 | 0.21 | -0.85 | 0.48 | 0.84 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -17.26 | -19.21 | -30.43 | -31.57 | -36.12 |
Income Taxes | 0.75 | 0.51 | 0.22 | 0.37 | 0.65 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -18.01 | -19.72 | -30.65 | -31.94 | -36.77 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -18.01 | -19.72 | -30.65 | -31.94 | -36.77 |
Earnings Per Share Data | 7/31/24 | 4/30/24 | 1/31/24 | 10/31/23 | 7/31/23 |
---|---|---|---|---|---|
Average Shares | 57.50 | 56.67 | 54.56 | 55.25 | 53.79 |
Diluted EPS Before Non-Recurring Items | -0.31 | -0.35 | -0.56 | -0.58 | -0.68 |
Diluted Net EPS (GAAP) | -0.31 | -0.35 | -0.55 | -0.58 | -0.68 |